part d event pde cost information
play

Part D Event (PDE) Cost Information Barbara Frank, M.S., M.P.H. - PowerPoint PPT Presentation

Part D Event (PDE) Cost Information Barbara Frank, M.S., M.P.H. Director of Workshops, Outreach, & Research University of Minnesota Part D Event (PDE) Cost Information Researchers cannot determine true costs to Medicare or Plan


  1. Part D Event (PDE) Cost Information Barbara Frank, M.S., M.P.H. Director of Workshops, Outreach, & Research University of Minnesota

  2. Part D Event (PDE) Cost Information  Researchers cannot determine “true” costs to Medicare or Plan for Prescription Drugs  Researchers can determine “point of sale” cost to beneficiary 2

  3. PDE Cost Information  To protect commercially sensitive plan data, the final rule addresses only the elements of PDE data and does not extend to Part D plan-specific bid data, rebates, risk-sharing, reinsurance, or payment information collected outside of a Part D event. 3

  4. PDE Cost Variables Gross Drug Cost  Gross Drug Cost* (Total Cost of Drug) is derived from the sum of 3 or 4 variables submitted by Plans to CMS, but not available to researchers: ˗ Ingredient Cost Paid ˗ Dispensing Fee Paid ˗ Total Amount Attributed to Sales Tax ˗ Beginning 2010, Vaccine Administration Fee  Mean = $65.20  Median = $21.70 4

  5. PDE Cost Variables  Gross Drug Cost = $65.20 ˗ Patient Pay Amount + $11.06 ˗ Low-Income Cost-Sharing Subsidy Amt + $14.67 ˗ Other True Out-of-Pocket Amount + $0.50 ˗ Patient Liability Reduction due to Other Payer Amt + $0.09 ˗ Covered D Plan Paid Amount + $35.32 ˗ Non-Covered Plan Paid Amount $3.55 $65.20 = 11.06 + 14.67+ 0.50 + 0.09 + 35.32 + 3.55 5

  6. PDE Cost Variables Gross Drug Cost  Limitation: Beginning with 2011 PDE data, the variable gross drug cost: ˗ Continues to include full cost of the drug ˗ Does NOT reflect any Coverage Gap Discounts that may have been applied ˗ Therefore, if the sum of the 6 variables is less than the gross drug cost (TOT_RX_CST_AMT), and if the event was in the coverage gap phase of the benefit, then the difference in these amounts can be assumed to be the gap discount amount. 6

  7. PDE Cost Variables  Gross Drug Cost = $65.20 (Bene in coverage gap) ˗ Patient Pay Amount + $5.53 ˗ Low-Income Cost-Sharing Subsidy Amt + $14.67 ˗ Other True Out-of-Pocket Amount + $0.50 ˗ Patient Liability Reduction due to Other Payer Amt + $0.09 ˗ Covered D Plan Paid Amount + $35.32 ˗ Non-Covered Plan Paid Amount $3.55 5.53 + 14.67+ 0.50 + 0.09 + 35.32 + 3.55 = $59.67 Difference of $5.53 assumed to be the gap discount to the beneficiary (i.e. 50% discount) 7

  8. PDE Cost Variables Patient Pay Amount  Patient Pay Amount – Amount that the beneficiary paid that is NOT reimbursed by a third party.  Amount contributes to True Out-of-Pocket amount (TrOOP) only for covered drugs.  Drug Coverage Status Codes ˗ Covered 99.34% ˗ Enhanced 0.44% ˗ OTC 0.22% 8

  9. PDE Cost Variables Patient Pay Amount ($)  Total population ˗ Minimum $0.00 ˗ Mean $11.06 ˗ 25 th Percentile is $0.00, 50% $3.10  Those with LICS Amounts ˗ Minimum $0.00 ˗ Mean $1.71 ˗ 25 th Percentile is 0.00, 50% $1.05  Without LICS Amounts ˗ Minimum $0.00 ˗ Mean $17.91 ˗ 25 th Percentile is $2.00, 50% $5.03 9

  10. PDE Cost Variables  Gross Drug Cost = ˗ Patient Pay Amount + ˗ Low-Income Cost-Sharing Subsidy Amt + ˗ Other True Out-of-Pocket Amount + ˗ Patient Liability Reduction due to Other Payer Amount + ˗ Covered D Plan Paid Amount + ˗ Non-Covered Plan Paid Amount 10

  11. PDE Cost Variables Low Income Cost Sharing Subsidy Amount (LICS)  Low Income Cost Sharing Subsidy Amount (LICS) – Amount the Plan reduced patient liability due to a beneficiary’s LICS status.  CMS reconciles prospective LICS payments made to Plans with actual LICS amounts incurred by Plan at point of sale. 11

  12. PDE Cost Variables Low Income Cost Sharing Subsidy Amount (LICS)  Total Population ˗ Minimum $0.00 ˗ Mean $14.67 ˗ Median $0.00 ˗ 75 th percentile is $5.95  LICS amounts only - Minimum $0.01 - Mean $34.69 - Median $8.71 - 75 th percentile is $31.23 12

  13. PDE Cost Variables  Gross Drug Cost = ˗ Patient Pay Amount + ˗ Low-Income Cost-Sharing Subsidy Amt + ˗ Other True Out-of-Pocket Amount + ˗ Patient Liability Reduction due to Other Payer Amount + ˗ Covered D Plan Paid Amount + ˗ Non-Covered Plan Paid Amount 13

  14. PDE Cost Variables Other True Out-of-Pocket Amount  Other TrOOP Amount – records all qualified third party payments on behalf of beneficiary.  Does not include LICS Subsidy Amount or Patient Pay Amount.  Examples are qualified State Pharmacy Assistance Programs, charities, or other TrOOP- eligible parties. 14

  15. Part D Event Variables Other True Out-of-Pocket Amount  Total Population  Minimum $0.00  Mean $0.50  Median $0.00  95 th percentile is $0.00  99 th percentile $5.73  When populated Mean = $23.58  Populated records 2.14% 15

  16. PDE Cost Variables Patient Liability Reduction Due to Other Payer Amount (PLRO)  Amount patient liability amount is reduced due to other benefits. Examples are VA and TRICARE. These other payers are not TrOOP-eligible and do not participate in Medicare Part D. 16

  17. PDE Cost Variables Patient Liability Reduction Due to Other Payer Amount (PLRO)  Minimum - negative amount??  Mean $0.09  99 th Percentile $0.00  Less than 0.4 % of records have PLRO amounts  When correctly populated, Mean = $24.09 17

  18. PDE Cost Variables  Gross Drug Cost = ˗ Patient Pay Amount + ˗ Low-Income Cost-Sharing Subsidy Amt + ˗ Other True Out-of-Pocket Amount + ˗ Patient Liability Reduction due to Other Payer Amount + ˗ Covered D Plan Paid Amount + ˗ Non-Covered Plan Paid Amount 18

  19. PDE Cost Variables Covered D Plan Paid Amount (CPP)  Minimum $0.00  Mean $35.32  Median $6.46  25 th Percentile is $0.00 19

  20. PDE Cost Variables  Gross Drug Cost = ˗ Patient Pay Amount + ˗ Low-Income Cost-Sharing Subsidy Amt + ˗ Other True Out-of-Pocket Amount + ˗ Patient Liability Reduction due to Other Payer Amount + ˗ Covered D Plan Paid Amount + ˗ Non-Covered Plan Paid Amount 20

  21. PDE Cost Variables Non-Covered Plan Paid Amount (NPP)  Total Population ˗ Minimum Negative Amount?? ˗ Mean $3.56 ˗ 75 th Percentile $0.00  When NPP populated ˗ Mean $11.04 ˗ Median $1.37 21

  22. PDE Cost Variables Non-Covered Plan Paid Amount (NPP)  The following patterns occur when costs are mapped to the defined standard benefit: ˗ When the plan pays more than what is covered in a given benefit phase under the standard benefit, the NPP will be a positive amount. ˗ When the plan and the defined standard benefit payment amounts are the same, the NPP is zero. ˗ When the plan pays less than what is covered in a given phase under the defined standard benefit, the NPP will be a negative amount. 22

  23. Non-Covered Plan Paid Amount (NPP) Example of Negative Amount  The beneficiary’s YTD total covered drug costs = $1,500. The beneficiary purchases a covered Part D drug for $100. The copay for this drug is $40.  Explanation: According to the standard benefit, the beneficiary is in the initial coverage period where the beneficiary pays 25% cost share and the plan pays 75%. In Plan B’s benefit structure, the beneficiary has a flat $40 copay, which is 40% of the total drug cost. The plan liability is $60 under Plan B’s benefit structure as compared with $75 under the standard defined benefit. The difference between the plan liability in the Plan’s benefit structure and the standard benefit plan structure is a supplemental benefit. In this case, the amount is negative because the plan paid less than under the defined standard. This amount is reported in the NPP field. 23

  24. Non-Covered Plan Paid Amount (NPP) Example of Negative Amount 24

  25. PDE Cost Variables  Drug costs are shared by ˗ Beneficiary Responsibility = » Patient Pay Amount + » LICS Amount + » Other TrOOP Amount + » PLRO Amount ˗ Net Amount Part D Plan paid for drug = » Covered D Plan Paid Amount + » Non-Covered Plan Paid Amount 25

  26. PDE Cost Variables Please note that CMS uses only the Covered D  Plan Paid Amount in the reconciliation with the Plan  Non- Covered Plan Paid Amount is “recouped” by the Plan through higher premiums for the Enhanced Benefits 26

  27. PDE Cost Variables  True Out-of-Pocket Cost (TrOOP) = ˗ Patient Pay Amount + ˗ LICS Amount + ˗ Other TrOOP Amount  MIN is $0.00 and Mean is $26.24 27

  28. PDE Cost Variables Summary  Gross Drug Cost = ˗ Patient Pay Amount + ˗ Low-Income Cost-Sharing Subsidy Amt + ˗ Other True Out-of-Pocket Amount + ˗ Patient Liability Reduction due to Other Payer Amount + ˗ Covered D Plan Paid Amount + ˗ Non-Covered Plan Paid Amount  $65.20 = 11.06 + 14.67+ 0.50 + 0.09 + 35.32 + 3.55  TrOOP = $26.24  Covered D Plan Paid Amount = $35.32 28

  29. PDE Cost Variables Catastrophic Coverage Code  Values  A = Attachment point met on event 0.25%  C = Above attachment point 8.35%  Blank = Attachment point not met 91.40% 29

  30. Top 10 Drugs by Cost 2009 Drug Name Drug Cost Drug Fills Drug Users $2,721,330,618 2,308,965 PLAVIX 15,091,816 $2,288,410,393 2,797,156 LIPITOR 16,124,928 $1,676,860,707 1,538,131 NEXIUM 8,186,015 $1,647,172,156 778,877 SEROQUEL 6,117,828 $1,585,291,207 1,107,900 ARICEPT 7,537,588 $1,394,195,358 1,360,521 ADVAIR DISKUS 5,919,728 $1,341,371,884 328,814 ZYPREXA 2,730,705 $1,188,291,746 839,030 ACTOS 5,105,667 $1,079,251,761 337,862 ABILIFY 2,210,032 30 $958,924,218 1,226,259 FLOMAX 6,533,806

Recommend


More recommend